| Page 1332 | Kisaco Research
 

Ashley Murphy

Director Integrated Digital Marketing
Rare Beauty

Ashley Murphy

Director Integrated Digital Marketing
Rare Beauty

Ashley Murphy

Director Integrated Digital Marketing
Rare Beauty
 

Lauren Jury

Director of Global Content and Social Media Strategy
bareMinerals

Lauren Jury is the Director of Global Content and Social Media Strategy at bareMinerals. She is responsible for leading the brand’s social presence globally, developing content that is effective and thumb-stopping, and growing the engaged bM community. 

Lauren Jury

Director of Global Content and Social Media Strategy
bareMinerals

Lauren Jury

Director of Global Content and Social Media Strategy
bareMinerals

Lauren Jury is the Director of Global Content and Social Media Strategy at bareMinerals. She is responsible for leading the brand’s social presence globally, developing content that is effective and thumb-stopping, and growing the engaged bM community. 

 Prior to joining bareMinerals in 2018, Lauren oversaw social media in the US market at Yves Saint Laurent Beauté. She also worked at global skincare brand Fresh, establishing the brand on social media internationally. She began her career in beauty on the editorial side at Condé Nast with published work in Vogue and Teen Vogue. 

Lauren is a proud alumna of Michigan State University where she earned her bachelor’s degree in advertising.

 

Wendy Anderson

Partner & Co-Founder
The Case For Her

Wendy Anderson is a Co-founder and Investing Partner at The Case for Her, a philanthropic investment portfolio addressing the key women’s health issues of menstruation and female sexual health & pleasure. A graduate of Queen’s University in Ontario, Canada, Wendy spent over a decade working in the financial industry before transitioning to impact investing at Futura Foundations, which she directs together with her husband, acting as Chair of Social Initiatives since 2009.

Wendy Anderson

Partner & Co-Founder
The Case For Her

Wendy Anderson

Partner & Co-Founder
The Case For Her

Wendy Anderson is a Co-founder and Investing Partner at The Case for Her, a philanthropic investment portfolio addressing the key women’s health issues of menstruation and female sexual health & pleasure. A graduate of Queen’s University in Ontario, Canada, Wendy spent over a decade working in the financial industry before transitioning to impact investing at Futura Foundations, which she directs together with her husband, acting as Chair of Social Initiatives since 2009. Wendy chairs the Board at Be Girl, a mission-driven design company addressing menstruation, is on the Executive Board of Women Moving Millions and sits on the advisory boards of both Saral Designs and The Center for Intimacy Justice.

 

Therese Maria Liechtenstein

Investor Director
M Ventures

Therese Liechtenstein, PhD, is a Principal in the Biotechnology team of M Ventures. Therese joined M Ventures in 2018. She was instrumental in the creation and financing of multiple companies of M Ventures portfolio, including FoRx Therapeutics and Anavo Therapeutics. Thera actively leads investments and represents M Ventures on the board of multiple portfolio companies. Previously Therese managed strategic projects for the Healthcare business of Merck KGaA in Darmstadt, Germany.

Therese Maria Liechtenstein

Investor Director
M Ventures

Therese Maria Liechtenstein

Investor Director
M Ventures

Therese Liechtenstein, PhD, is a Principal in the Biotechnology team of M Ventures. Therese joined M Ventures in 2018. She was instrumental in the creation and financing of multiple companies of M Ventures portfolio, including FoRx Therapeutics and Anavo Therapeutics. Thera actively leads investments and represents M Ventures on the board of multiple portfolio companies. Previously Therese managed strategic projects for the Healthcare business of Merck KGaA in Darmstadt, Germany. Prior to Merck KGaA, Darmstadt, Germany, Therese was a client relationship manager in the field of wealth preservation, at Industrie- & Finanzkontor Ets. Therese comes from an academic background receiving her PhD in Immuno-Oncology from University College London, an MSc in Biomedical Sciences from the University of Amsterdam, and a BA in Biology and Business studies from New York University.